Feedback Share Discussion Threads

[ged5] 29/4/2020 15:28

Very disappointing afternoon performance. I have to be honest and sold a small amount of my trading shares at about 1.5p. Be silly not to make some money, after all one could buy at .45p not so long ago. I still hold all my core shares and intend to keep them until Bleepa is a proven winner.

Let's have a nice steady rise from here.

[yump] 29/4/2020 15:14

I guess that's where longer termers have an advantage. If, of course our/my assumption is that Bleepa really is something with a longer term future. If there's more people with that view, I guess the share price will hold up more than it has previously.

[sonie01] 29/4/2020 15:09

True yump, day traders taking profits

[yump] 29/4/2020 14:59

There'll be quite a few who've doubled their money and couldn't give a XXXX about FDBK.

[digger2779] 29/4/2020 14:46

Disappointing to see it walked down. Big order lurking perhaps?

[yump] 29/4/2020 13:52

Actually, although I haven't studied it, rises could simply be a function of how many shares are sloshing around trading at any one time. We've all seen stocks where small volumes hike the price and there's not much selling. FDBK has had some big volumes recently and that includes big volumes of selling. No way of guessing who and why.

[yump] 29/4/2020 13:49

LR2

"Now if only I could figure out why people are lumping into that pile of junk IQAI.!"

Didn't you know, penny stock price rises are inversely proportional to the usefulness of the product... ;-)

[lr2] 29/4/2020 11:59

Admiration with just a splash of cynicism Ged. In truth, happy to see today's rise. Now if only I could figure out why people are lumping into that pile of junk IQAI.

[ducatiman] 29/4/2020 11:56

Right break over, back to the key work. More blue please and/or the long awaited update.

[ged5] 29/4/2020 11:54

Good morning LR2. A little cynical today when we've had such fun. I see we're beginning to attract some discerning investors/traders/posters in some part thanks to you?

Let's hope FDBK deliver!

Riggerbeautz, there's plenty of information in the header but feel free to ask questions. There's a few who are up to speed here.

[ducatiman] 29/4/2020 11:53

Anyone watching iqai? Hmmm.

[ducatiman] 29/4/2020 11:52

He is, he won’t have added though as he goes by close prices.

[lr2] 29/4/2020 11:50

He's good at what he does, Duc.

[ducatiman] 29/4/2020 11:47

I see SSB got it spot on!

[lr2] 29/4/2020 11:43

Morning Ged. I see last week's options are in the money. Clever boys. Such timing.

[riggerbeautz] 29/4/2020 11:39

Thanks Ged, I’ll look more and maybe have some questions if you can help. I’ve gone from dipping a toe to several toes and inching towards a foot and managed to gain a few free ones trading.

I’ve read back about 1,000 posts, I’ll cover the rest over the weekend.

Edit: you too Pete

[petekand] 29/4/2020 11:37

Rigger
£10/month/per user.
Anyhow we are now seriously lagging the sector. Shares which were under a penny a few weeks back are now seeing up days of 3p a time!
Fdbk will follow soon particularly as we have covid facing products ready to go.

[ged5] 29/4/2020 11:32

Hi Riggerbeautz,

This is a very small outfit at the moment. FDBK has relied on income (about 560K) from sales in TexRAD research and Cadran. There was a recent announcement about a licence to upgrade fluoroscopy equipment in the US. I've been asking for some time how much FDBK will get.

Also we should get royalties of any sales of Stonechecker, now owned by IQAI.

Tom Oakley is the new CEO. He is young and seems to have plenty of energy. He answers some questions but ignores some which he could answer.

FDBK is all about Bleepa now. If it takes off in the NHS there is great potential worldwide. There are some competitors (loosely) but FDBK will work with any Dicom and allows medical images to be transferred and annotated. That's it's USP.

[riggerbeautz] 29/4/2020 11:17

Forgive the newcomer question, I’ve been quietly accumulating here and trading a few but can anyone help me with a revenue question on Bleepa please.

Get that it’s being provided free at present but are there any future cost and margin figures available.

[ged5] 29/4/2020 10:20

Bleepa maybe not that amazing but it is taken from Cadran which is perhaps fairly amazing and some might consider it to be very amazing.

The Cadran platform provides a suite of medical imaging tools for decision support. The Cadran range includes the picture archiving communication system (PACS) to provide decision support for scan analysis, diagnostic workstations which provide secure remote access to view scans on demand, and products to securely share and transport patient data. Visit www.fbk.com.

[coldspring] 29/4/2020 10:18

NHS is a v difficult market to get into but once you are in you are in. It also enables remote working, covid will run for a good while yet.

[yump] 29/4/2020 10:13

The technology is not that amazing - its an enhanced app. and FDBK still have to make money out of Bleepa.

However it will be around for a long time, unlike products or services in many other stocks that are having a temporary jump. Plus, this sort of accelerated exposure is a marketing dream, even if it is lucky.

[wimbled] 29/4/2020 10:04

Good stuff...........breakout

[ged5] 29/4/2020 10:02

Nice chart. Now we could do with some positive news.

[philjeans] 29/4/2020 09:28

BLEEPA will be used long after COVID has gone - amazing tech for a modern NHS.

Bargain still here.